Anosmia/Hyposmia is a Good Predictor of Coronavirus Disease 2019 (COVID-19) Infection: A Meta-Analysis

Abstract

Introduction The number of positive cases and deaths from the coronavirus disease 2019 (COVID-19) is still increasing. The early detection of the disease is very important. Olfactory dysfunction has been reported as the main symptom in part of the patients. Objective To analyze the potential usefulness of anosmia or hyposmia in the detection of the COVID-19 infection. Data Synthesis We systematically searched the PubMed Central database using specific keywords related to our aims until July 31st, 2020. All articles published on COVID-19 and anosmia or hyposmia were retrieved. A statistical analysis was performed using the Review Manager (RevMan, Cochrane, London, UK) software, version 5.4. A total of 10 studies involving 21,638 patients were included in the present analysis. The meta-analysis showed that anosmia or hyposmia is significantly associated with positive COVID-19 infections (risk ratio [RR]: 4.56; 95% confidence interval [95%CI]: 3.32–6.24; p < 0.00001; I2 = 78%, random-effects modeling). Conclusion The presence of anosmia or hyposmia is a good predictor of positive COVID-19 infections. Patients with onset of anosmia or hyposmia should take the test or undergo screening for the possibility of COVID-19 infection.

Human immunodeficiency virus and mortality from coronavirus disease 2019: A systematic review and meta-analysis

“…2 The COVID-19 disease has various clinical manifestations, ranging from mild symptoms such as fever, cough and anosmia to life-threatening conditions including shock, respiratory failure, arrhythmia, overwhelming sepsis and neurological impairment. 3,4 Meta-analyses have identified several comorbidities, 5,6,7,8,9 medicines 10,11 and abnormal laboratory test results 12,13 associated with a poor outcome. Persons living with human immunodeficiency virus (PLWH) are an at-risk population in view of their impaired immunity.…”

Dipeptidyl peptidase 4 (DPP4) inhibitor and outcome from coronavirus disease 2019 (COVID-19) in diabetic patients: a systematic review, meta-analysis, and meta-regression

“…This global pandemic disease has caused a significant impact on the economic and health aspects around the world. The manifestation of this disease can be varied from asymptomatic or consist of mild symptoms such as cough and fever to severe and life-threatening acute respiratory distress syndrome (ARDS), sepsis, multi-organ failure, and death [1,2]. There are several comorbid conditions which are associated with the development of severe outcome and mortality from COVID-19, including diabetes [3][4][5][6][7][8].…”

Parkinson's disease may worsen outcomes from coronavirus disease 2019 (COVID-19) pneumonia in hospitalized patients: A systematic review, meta-analysis, and meta-regression

“…Although most patients are thought to have a favorable prognosis, some individuals are more prone to develop severe manifestations, including fatal pneumonia that eventually results in death. 2 , 3 People with pre-existing medical conditions (e.g. hypertension, diabetes, coronary heart disease), older age, and male sex appear linked to more severe manifestations and mortality of COVID-19.…”